Blood Analyser

Blood Analyser Market Outlook

The global blood analyser market is projected to reach approximately USD 8.5 billion by 2035, growing at a compound annual growth rate (CAGR) of around 7.2% during the forecast period from 2025 to 2035. This growth is being driven by an increasing prevalence of chronic diseases, an aging population, and a growing demand for advanced diagnostic techniques. Furthermore, technological advancements in blood analysis, such as automation and the development of point-of-care devices, are also contributing significantly to market expansion. The rising awareness about blood donation and the need for accurate and timely diagnosis are factors enhancing the demand for blood analysers in various healthcare settings. Additionally, the integration of artificial intelligence (AI) and machine learning (ML) technologies into blood analysers is expected to boost their capabilities, enhance accuracy, and streamline operations, further propelling market growth.

Growth Factor of the Market

The blood analyser market is experiencing robust growth due to a convergence of factors that are reshaping the healthcare landscape. Firstly, the increasing prevalence of blood-related disorders and conditions, such as anemia, hemophilia, and infectious diseases, necessitates the use of efficient blood analysis tools for accurate diagnosis and monitoring. Moreover, the rise in geriatric populations globally is contributing to a surge in demand for healthcare services, thereby propelling the need for advanced blood analysers. Technological innovations, such as the introduction of portable and user-friendly devices, have made blood analysis more accessible in various settings, including remote and underserved areas. Additionally, government initiatives aimed at promoting healthcare infrastructure and services in developing regions are further stimulating market growth. Lastly, increased investments in research and development (R&D) by key players are paving the way for the introduction of novel blood analysis technologies, which are anticipated to enhance the functionality and performance of blood analysers in the foreseeable future.

Key Highlights of the Market

• The global blood analyser market is projected to reach USD 8.5 billion by 2035.
• Growing prevalence of chronic diseases is a significant market driver.
• Technological advancements such as automation are reshaping blood analysis.
• AI and ML integration is enhancing the capabilities of blood analysers.
• Increased government initiatives are promoting healthcare infrastructure.

By Product Type

Instruments :

The instruments segment is a vital component of the blood analyser market, encompassing various devices used for blood analysis. This segment includes fully automated analyzers, semi-automated analyzers, and point-of-care testing devices. Fully automated analyzers are preferred in clinical laboratories due to their ability to process large volumes of tests quickly and accurately, making them indispensable in high-throughput settings. In semi-automated analyzers, manual intervention is required, which may be suitable for smaller laboratories or clinics. The point-of-care testing devices are gaining traction due to their portability and ease of use, allowing healthcare professionals to conduct tests in various settings, including emergency rooms and remote locations. The continuous innovations in instrument designs, improving accuracy and efficiency, are expected to propel this segment's growth significantly over the forecast period.

Reagents :

The reagents segment is crucial for the functioning of blood analysers, as they are essential for conducting various tests. Reagents are substances or compounds that react with blood samples to identify specific components like glucose, cholesterol, and other biochemical markers. The market for reagents is expanding due to the increasing utilization of advanced testing protocols and the rising demand for precise diagnostic outcomes. Manufacturers are continuously striving to develop high-quality reagents that minimize interference and enhance the reliability of test results. Additionally, the growth in personalized medicine and targeted therapies necessitates the use of specialized reagents, further boosting this segment. The continual advancements in reagent formulations that cater to diverse testing needs are projected to drive the market for reagents substantially during the forecast period.

Consumables :

The consumables segment includes various items such as test kits, blood collection tubes, and sample preparation materials that are integral to the blood analysis process. This segment is witnessing significant growth owing to the increasing volume of diagnostic tests performed in healthcare facilities. As blood analysers require regular replenishment of consumables for ongoing operations, the demand for these items is consistent. Furthermore, innovations in consumables designed for ease of use and improved accuracy are likely to encourage adoption in laboratories and healthcare facilities. The rising focus on quality assurance and regulatory compliance in the healthcare sector is also driving demand for high-quality consumables. As hospitals and diagnostic centers aim to streamline operations and enhance patient outcomes, the consumables segment is expected to experience substantial growth over the coming years.

By Application

Disease Diagnosis :

The disease diagnosis application segment is critical in driving the demand for blood analysers, as accurate and timely diagnosis is essential for effective patient management. With the increasing incidence of chronic diseases such as diabetes, cardiovascular disorders, and infectious diseases, the need for advanced diagnostic tools has surged. Blood analysers play a pivotal role in identifying disease markers, enabling physicians to formulate effective treatment plans. Continuous advancements in diagnostic techniques allow for the quick identification of diseases, which is crucial for patient outcomes. Moreover, the integration of multiplex testing capabilities into blood analysers enhances their utility in diagnosing multiple conditions from a single sample, further driving the growth of this segment.

Blood Count :

The blood count application segment is essential for evaluating a patient's overall health and detecting various disorders, including anemia and infections. Complete blood count (CBC) tests, which analyze different blood components such as red blood cells, white blood cells, and platelets, are among the most commonly performed tests in clinical laboratories. The increasing demand for routine health check-ups and monitoring has significantly boosted the demand for blood count tests. Enhanced precision and automation in blood count analysis have led to quicker turnaround times, which is highly valued in clinical settings. As healthcare providers strive to improve patient care through regular monitoring, this segment is expected to witness considerable growth throughout the forecast period.

Blood Chemistry Analysis :

The blood chemistry analysis application segment encompasses tests that assess various biochemical components in the blood, such as electrolytes, enzymes, and hormones. This segment is experiencing growth due to the rising prevalence of metabolic disorders and the need for regular monitoring of biochemical markers. Blood chemistry tests are crucial for diagnosing and managing numerous health conditions, enabling healthcare professionals to gain insights into a patient's metabolic state. The development of advanced analytical techniques that provide more accurate and rapid results is expected to enhance this segment's growth. As the demand for preventive healthcare continues to rise, blood chemistry analysis will play a pivotal role in disease prevention and management.

Blood Typing :

The blood typing application segment is fundamental in transfusion medicine and transplant compatibility testing. Accurate blood typing is critical for ensuring patient safety during blood transfusions and organ transplants. The rising number of surgical procedures and increasing awareness regarding blood donation are driving the demand for blood typing tests. Technological advancements, including the development of automated blood typing systems, have enhanced the efficiency and reliability of these tests. The integration of molecular techniques in blood typing is also gaining traction, as it offers improved accuracy. As healthcare providers prioritize patient safety and compatibility in transfusion practices, this segment is projected to grow significantly over the forecast period.

By End User

Hospitals :

The hospitals segment is the largest end-user category in the blood analyser market, as hospitals are primary healthcare providers that conduct a multitude of diagnostic tests daily. The increasing patient inflow, coupled with the growing prevalence of chronic diseases, has led hospitals to invest in advanced blood analyser systems to enhance diagnostic capabilities and patient care. Additionally, the rising focus on quality healthcare services drives hospitals to adopt automated and efficient blood analysis systems to reduce human error and improve turnaround time for test results. The ongoing expansion of hospital infrastructure, especially in developing regions, further propels the demand for blood analysers. As healthcare systems continue to evolve and emphasize timely diagnosis, the hospitals segment will remain a significant contributor to the overall blood analyser market.

Diagnostic Centers :

Diagnostic centers are specialized institutions that focus on providing various laboratory testing services, including blood analysis. The demand for blood analysers in diagnostic centers is growing due to the increasing number of individuals seeking preventive health check-ups and timely diagnostic services. These centers are crucial for early disease detection and monitoring, and they often require advanced blood analysers to ensure accurate and efficient testing. The rise of entrepreneurial diagnostic centers, particularly in urban areas, is significantly contributing to the growth of this segment. Moreover, collaboration between diagnostic centers and hospitals is also on the rise, leading to increased demand for high-quality blood analysis services. As patient awareness regarding the importance of regular health assessments grows, diagnostic centers are expected to play an increasingly prominent role in the blood analyser market.

Research Institutes :

Research institutes are crucial players in the blood analyser market, as they conduct extensive studies and experiments to develop new diagnostic techniques and improve existing ones. The increasing focus on research and development in areas such as genomics, proteomics, and personalized medicine is driving the demand for advanced blood analysers in these institutions. The utilization of blood analysers in research aids in understanding disease mechanisms and the development of targeted therapies. Furthermore, collaborations between research institutes and healthcare providers are becoming more common, enhancing the application of blood analysis technologies in translational medicine. As innovation continues to influence the healthcare landscape, the research institutes segment is expected to grow substantially, contributing to overall market expansion.

Blood Banks :

Blood banks are essential facilities that collect, test, and distribute blood products for transfusions. The increasing need for safe and compatible blood products due to a rise in surgical procedures and trauma cases is driving the demand for blood analysers in blood banks. Automated blood analysers facilitate the efficient testing of blood samples for infectious diseases, blood typing, and compatibility testing, ensuring patient safety during transfusions. The growing emphasis on blood donation awareness campaigns is further propelling the demand for blood banks, leading to increased testing requirements. Moreover, as blood banks adopt advanced technologies to improve their services and ensure the highest standards of safety, the blood banks segment is projected to experience significant growth during the forecast period.

By Technology

Biochemical Analysis :

The biochemical analysis technology segment is pivotal to the blood analyser market, as it encompasses various techniques used to measure the concentrations of different biochemical markers in blood samples. Biochemical analysis is critical for diagnosing a wide range of conditions, including diabetes, liver diseases, and metabolic disorders. The integration of advanced analytical methods, such as spectrophotometry and electrochemistry, has enhanced the sensitivity and specificity of biochemical tests. Moreover, the growing focus on preventive healthcare is driving the demand for routine biochemical testing, propelling this segment's growth. As technological advancements continue to evolve in this area, the biochemical analysis segment is expected to thrive as a significant contributor to the overall blood analyser market.

Immunological Analysis :

The immunological analysis technology segment involves techniques that assess immune responses and detect specific antibodies in blood samples. This technology is instrumental in diagnosing infectious diseases, autoimmune disorders, and allergies. The increasing prevalence of infectious diseases, coupled with rising awareness about immunological testing, is driving the demand for blood analysers equipped with immunological analysis capabilities. Furthermore, advancements in immunoassays, such as enzyme-linked immunosorbent assays (ELISA) and lateral flow assays, are enhancing the accuracy and efficiency of these tests. As healthcare providers continue to prioritize accurate disease diagnosis, the immunological analysis segment is anticipated to grow significantly over the forecast period.

Molecular Analysis :

The molecular analysis technology segment is emerging as a pivotal part of the blood analyser market, driven by advancements in genomics and molecular biology. This technology focuses on analyzing genetic material and identifying specific biomarkers associated with various diseases. Molecular analysis offers high sensitivity and specificity, making it invaluable for diagnosing genetic disorders, infectious diseases, and cancers. The increasing adoption of personalized medicine and targeted therapies is fueling demand for molecular testing, as healthcare providers seek to tailor treatments based on individual patient profiles. Additionally, the integration of polymerase chain reaction (PCR) and next-generation sequencing (NGS) technologies into blood analysers is further propelling this segment's growth. As research and clinical practices evolve, the molecular analysis segment is expected to experience substantial expansion in the coming years.

Hematological Analysis :

The hematological analysis technology segment encompasses techniques used to evaluate the cellular components of blood, such as red blood cells, white blood cells, and platelets. This analysis is fundamental for diagnosing various blood disorders, including anemia, leukemias, and other hematological conditions. The continuous development of automated hematology analyzers has significantly improved the efficiency and accuracy of blood cell counting and classification. The rising prevalence of blood-related diseases and the growing focus on early detection and monitoring are key factors driving the demand for hematological analysis. As healthcare providers aim to uphold high standards of patient care, the hematological analysis segment is expected to witness considerable growth throughout the forecast period.

By Region

North America is anticipated to dominate the blood analyser market throughout the forecast period, accounting for approximately 40% of the total market share. The region's leadership in the market is bolstered by advanced healthcare infrastructure, a high prevalence of chronic diseases, and robust investments in medical technology. Additionally, the presence of leading market players and continuous technological innovations significantly contribute to the growth of the blood analyser market in North America. The increasing emphasis on preventive care and early disease detection is further enhancing the demand for advanced blood analysis systems. The North American market is expected to grow at a CAGR of 6.5%, as healthcare providers increasingly adopt automated and innovative solutions to improve diagnostic efficiency.

Europe is expected to follow closely, accounting for approximately 30% of the global blood analyser market. The region is characterized by an aging population, which contributes to a higher incidence of chronic diseases and necessitates comprehensive blood testing services. European countries are making significant investments in healthcare infrastructure and technology, facilitating the growth of the blood analyser market. The emphasis on research and development in diagnostic technologies further strengthens the market in Europe, as healthcare providers and research institutions collaborate to enhance testing capabilities. The European market is projected to grow at a CAGR of 7.0%, driven by innovation and increasing healthcare expenditures.

Opportunities

As the blood analyser market continues to evolve, numerous opportunities are emerging across different segments. One significant opportunity is the growing demand for point-of-care testing (POCT) solutions that allow for rapid and accurate blood analysis outside traditional laboratory settings. The increasing prevalence of chronic diseases and the need for immediate diagnostic results are driving this trend, especially in remote and underserved areas. Companies that focus on developing portable and user-friendly blood analysers can capture a significant share of this emerging market. Additionally, the integration of advanced technologies, such as artificial intelligence and machine learning, presents opportunities for innovation in blood analysis, enabling more accurate diagnostics and efficient workflows. These advancements can facilitate the development of personalized medicine approaches, further enhancing patient outcomes and the overall effectiveness of healthcare delivery.

Another area ripe with opportunities is the expansion of blood analysis services in emerging markets. Rapid urbanization, increasing healthcare expenditures, and a growing awareness of the importance of regular health check-ups are driving demand in regions such as Asia-Pacific, Latin America, and the Middle East & Africa. Companies that strategically invest in these markets can benefit from the rising need for advanced blood analysers and diagnostic services. Collaborations with local healthcare providers and governments can facilitate market entry and promote the adoption of innovative blood analysis technologies. Furthermore, the ongoing advancements in telemedicine and remote patient monitoring present opportunities for integrating blood analysers into digital health platforms, enhancing accessibility and convenience for patients seeking timely and efficient healthcare services.

Threats

While the blood analyser market presents numerous opportunities, it is also fraught with challenges and threats that can impact growth. One of the major threats is the increasing competition among market players, leading to price wars and reduced profit margins. The entry of new players and the rapid pace of technological advancements can create a saturated market, making it difficult for established companies to maintain their competitive edge. Additionally, the stringent regulatory requirements governing medical devices can pose challenges for manufacturers as they strive to ensure compliance while innovating and bringing new products to market. The process of obtaining regulatory approvals can be time-consuming and costly, hindering the speed of product development and market entry, especially for small and medium-sized enterprises.

Another significant threat is the potential for economic downturns and reductions in healthcare budgets, which can affect the procurement of blood analysers in both public and private health sectors. Economic instability can lead to decreased investments in healthcare infrastructure and technology, limiting opportunities for market growth. Furthermore, the ongoing challenges related to supply chain disruptions, exacerbated by global events such as pandemics and geopolitical tensions, can impact the availability of components and materials needed for blood analysers. These disruptions may lead to delays in production and delivery schedules, ultimately affecting company revenues and market stability. As the industry navigates these threats, it will be crucial for companies to adopt strategies that enhance resilience and ensure sustained growth in the blood analyser market.

Competitor Outlook

• Abbott Laboratories
• Roche Diagnostics
• Becton, Dickinson and Company
• Siemens Healthineers
• Johnson & Johnson
• Thermo Fisher Scientific
• Danaher Corporation
• Sysmex Corporation
• Mindray Medical International Limited
• Horiba Medical
• Beckman Coulter, Inc.
• Agilent Technologies
• PerkinElmer, Inc.
• HemoCue AB
• Greiner Bio-One International GmbH

The competitive landscape of the blood analyser market is characterized by a mix of established players and emerging companies striving to innovate and capture market share. Major players such as Abbott Laboratories and Roche Diagnostics are at the forefront of technological advancements and product development, often leading the market with their comprehensive portfolios of blood analysers and diagnostic solutions. These companies invest heavily in research and development, focusing on improving accuracy and efficiency in blood analysis while also expanding their market presence through strategic partnerships and acquisitions. The competitive dynamics are shifting as players explore collaborations with technology firms to integrate AI and machine learning into their products, aiming to enhance diagnostic accuracy and streamline workflows.

Furthermore, companies like Siemens Healthineers and Becton, Dickinson and Company are leveraging their extensive distribution networks to ensure widespread availability of their blood analysers. This approach allows them to strengthen their foothold in both developed and emerging markets. Additionally, the focus on customer-centric solutions, including after-sales support and training, is becoming increasingly important in differentiating offerings and building brand loyalty. Companies are also being challenged to adapt to regulatory changes and ensure compliance with evolving healthcare standards while maintaining cost-effectiveness in their product offerings.

Emerging players and small to medium-sized enterprises are also gaining traction in the blood analyser market by offering specialized products or niche solutions. These companies are often agile and able to respond quickly to changing market demands, allowing them to carve out specific segments within the broader blood analysis landscape. Many of these players focus on developing point-of-care testing devices, capitalizing on the increasing demand for rapid diagnostic solutions. Innovations in product design, such as user-friendly interfaces and portable devices, contribute to their competitive advantage, enabling them to address the needs of healthcare providers and patients alike.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 HemoCue AB
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Horiba Medical
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Johnson & Johnson
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 PerkinElmer, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Roche Diagnostics
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Sysmex Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Abbott Laboratories
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Danaher Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Agilent Technologies
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Siemens Healthineers
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Beckman Coulter, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Thermo Fisher Scientific
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Becton, Dickinson and Company
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Greiner Bio-One International GmbH
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Mindray Medical International Limited
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Blood Analyser Market, By End User
    • 6.1.1 Hospitals
    • 6.1.2 Diagnostic Centers
    • 6.1.3 Research Institutes
    • 6.1.4 Blood Banks
    • 6.1.5 Others
  • 6.2 Blood Analyser Market, By Technology
    • 6.2.1 Biochemical Analysis
    • 6.2.2 Immunological Analysis
    • 6.2.3 Molecular Analysis
    • 6.2.4 Hematological Analysis
    • 6.2.5 Others
  • 6.3 Blood Analyser Market, By Application
    • 6.3.1 Disease Diagnosis
    • 6.3.2 Blood Count
    • 6.3.3 Blood Chemistry Analysis
    • 6.3.4 Blood Typing
    • 6.3.5 Others
  • 6.4 Blood Analyser Market, By Product Type
    • 6.4.1 Instruments
    • 6.4.2 Reagents
    • 6.4.3 Consumables

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Blood Analyser Market by Region
  • 10.4 Latin America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 Brazil
      • 10.4.1.2 Argentina
      • 10.4.1.3 Mexico
  • 10.5 North America - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 USA
      • 10.5.1.2 Canada
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Blood Analyser market is categorized based on

By Product Type

• Instruments
• Reagents
• Consumables

By Application

• Disease Diagnosis
• Blood Count
• Blood Chemistry Analysis
• Blood Typing
• Others

By End User

• Hospitals
• Diagnostic Centers
• Research Institutes
• Blood Banks
• Others

By Technology

• Biochemical Analysis
• Immunological Analysis
• Molecular Analysis
• Hematological Analysis
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Abbott Laboratories
• Roche Diagnostics
• Becton, Dickinson and Company
• Siemens Healthineers
• Johnson & Johnson
• Thermo Fisher Scientific
• Danaher Corporation
• Sysmex Corporation
• Mindray Medical International Limited
• Horiba Medical
• Beckman Coulter, Inc.
• Agilent Technologies
• PerkinElmer, Inc.
• HemoCue AB
• Greiner Bio-One International GmbH